Browse

You are looking at 151 - 200 of 244 items for :

  • Clinical Resources x
  • Refine by Access: All content x
Clear All
Restricted access

Chapter 5: Medications Used to Treat Opioid Overdose and Maintenance Treatment Modalities

Kathryn A. Nash and Jeffrey P. Bratberg

Restricted access

Chapter 50: Osteoporosis and Osteomalacia

Laura M. Borgelt and Danielle R. Fixen

Restricted access

Chapter 51: Gout and Hyperuricemia

Jasmine D. Gonzalvo

Restricted access

Chapter 52: Myopathy

Craig Williams

Restricted access

Chapter 53: Weight Gain

Amy Heck Sheehan

Restricted access

Chapter 54: Temperature Dysregulation

Susan M. Wilson and Ian A. Ross

Restricted access

Chapter 55: Ototoxicity

Monica L. Miller

Restricted access

Chapter 56: Oral Manifestations of Systemically Administered Drugs

Ashley H. Meredith

Restricted access

Chapter 57: Neoplastic Diseases

Sandra Cuellar and Christina Mactal Haaf

Restricted access

Chapter 58: Teratogenicity

Kylie N. Barnes

Restricted access

Chapter 6: Drug Allergy and Cutaneous Diseases

Lynne M. Sylvia

Restricted access

Chapter 6: Pain Management Considerations

Theodore V. Parran Jr.

Restricted access

Chapter 7: Detection and Deterrence of Prescription Medication Misuse and Diversion

Michael G. O’Neil and Sarah T. Melton

Restricted access

Chapter 7: Systemic Lupus Erythematosus-Like Syndrome

Karen W. Lee and Matthew F. Ambury

Restricted access

Chapter 8: Caring for the Pregnant Woman with Opioid Use Disorder and Infants with Neonatal Abstinence Syndrome

Carla Worley Saunders, Sarah T. Melton, and Michael G. O’Neil

Restricted access

Chapter 8: Photosensitivity

Julie M. Koehler

Restricted access

Chapter 9: Alopecia, Hirsutism, and Hypertrichosis

Kristine E. Keplar

Restricted access

Chapter 9: Substance Use Disorders in the Pharmacy Professional

Wallace J. Cross and Jeffrey N. Baldwin

Restricted access
Cover Drug-Induced Diseases

Drug-Induced Diseases

Prevention, Detection, and Management

Edited by James E. Tisdale and Douglas A. Miller

Restricted access
Cover The Pharmacist’s Guide to Opioid Use Disorders

The Pharmacist’s Guide to Opioid Use Disorders

Edited by Merrill Norton, Jeffrey N. Baldwin, and Michael G. O’Neil

Restricted access

1. Introduction to Anticoagulation Management

William E. Dager, Michael P. Gulseth, and Edith A. Nutescu

Restricted access

10. Transitions in Care—Periprocedural Bridging and Transitions Between Agents

Jessica Rimsans, Katelyn W. Sylvester, and John Fanikos

Restricted access

11. Considerations in Special Populations

Thaddaus Hellwig and William E. Dager

Restricted access

12. Venous Thromboembolism Prevention

Paul P. Dobesh and Kelsey Aker

Restricted access

13. Venous Thromboembolism Treatment

Snehal H. Bhatt and Michael P. Gulseth

Restricted access

14. Atrial Fibrillation

Daniel M. Witt

Restricted access

15. Acute Coronary Syndromes

Sarah A. Spinler

Restricted access

16. Prosthetic Heart Valves

Douglas C. Anderson

Restricted access

17. Mechanical Circulatory Support Devices

Christopher Paciullo, Laura Baumgartner, and Lauren Roller

Restricted access

18. Heparin-Induced Thrombocytopenia

William E. Dager

Restricted access

19. Pregnancy

Nancy L. Shapiro

Restricted access

2. Warfarin

Ann K. Wittkowsky

Restricted access

20. Pediatrics

Kirsten H. Ohler

Restricted access

21. Coagulation Laboratory Considerations

Robert C. Gosselin and Maureen A. Smythe

Restricted access

22. Thrombophilias

Jessica B. Michaud and Canice A. Coan

Restricted access

23. Models and Standards of Anticoagulation Care Delivery

Nathan P. Clark and Paul B. Shaw

Restricted access

24. Regulatory and Practice Resources

Michael P. Gulseth and William E. Dager

Restricted access

3. Unfractionated Heparin

William E. Dager

Restricted access

4. Low Molecular Weight Heparin and Fondaparinux

Zachary Stacy and Sara K. Richter

Restricted access

5. Parenteral Direct Thrombin Inhibitors

William E. Dager and A. Joshua Roberts

Restricted access

6. Thrombolytic Considerations When Used with Anticoagulants

Toby C. Trujillo and Tyree H. Kiser

Restricted access

7. Direct Oral Anticoagulants

Allison E. Burnett and Candice L. Garwood

Restricted access

8. Anticoagulation Reversal: Part I—Pharmacology of Agents Used for Reversal

Lance J. Oyen and Scott A. Chapman

Restricted access

9. Anticoagulation Reversal: Part II—Clinical Application

William E. Dager

Restricted access
Cover Anticoagulation Therapy

Anticoagulation Therapy

A Clinical Practice Guide

Edited by William E. Dager, Michael P. Gulseth, and Edith A. Nutescu

Restricted access

Chapter 1: Introduction to Opioid Conversion Calculations

Edited by Mary Lynn McPherson

Restricted access

Chapter 2: Converting Among Routes and Formulations of the Same Opioid

Edited by Mary Lynn McPherson

Restricted access

Chapter 3: Converting Among Routes and Formulations of Different Opioids

Edited by Mary Lynn McPherson

Restricted access

Chapter 4: Titrating Opioid Regimens: Around the Clock and to the Rescue!

Edited by Mary Lynn McPherson

Restricted access

Chapter 5: Transdermal and Parenteral Fentanyl Dosage Calculations and Conversions

Edited by Mary Lynn McPherson